136 related articles for article (PubMed ID: 31103372)
1. Reactivity with the EpCAM-specific antibodies MOC-31 and Ber-Ep4 in plasma cell neoplasms: a potential diagnostic pitfall in cytology samples.
Weimholt RC; Sharifai N; Abro B; Vij K; Bernadt C
J Am Soc Cytopathol; 2019; 8(5):265-269. PubMed ID: 31103372
[TBL] [Abstract][Full Text] [Related]
2. MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study.
Pai RK; West RB
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):202-6. PubMed ID: 19391212
[TBL] [Abstract][Full Text] [Related]
3. The utility of claudin-4 versus MOC-31 and Ber-EP4 in the diagnosis of metastatic carcinoma in cytology specimens.
Najjar S; Gan Q; Stewart J; Sneige N
Cancer Cytopathol; 2023 Apr; 131(4):245-253. PubMed ID: 36522809
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
5. Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4.
Naso JR; Churg A
Hum Pathol; 2020 Jun; 100():10-14. PubMed ID: 32333920
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology.
Oda T; Ogata S; Kawaguchi S; Minabe S; Dokyu M; Takahashi H; Kumazawa F; Shimazaki H; Takano M; Hase K; Ozeki Y; Kanoh S; Nakanishi K
Diagn Cytopathol; 2016 Jun; 44(6):499-504. PubMed ID: 27015745
[TBL] [Abstract][Full Text] [Related]
7. Ber-EP4 staining in effusion cytology: A potential source of false positives.
Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Metastatic Carcinoma Using Body Cavity Fluid Specimens: A Comparison of Diagnostic Panels.
Sridakhun N; Intarawichian P; Thanee M; Watcharadetwittaya S
Acta Cytol; 2023; 67(3):257-264. PubMed ID: 36513033
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4 immunohistochemistry is a useful pan-carcinoma marker for serous effusion specimens.
Vojtek M; Walsh MD; Papadimos DJ; Shield PW
Cytopathology; 2019 Nov; 30(6):614-619. PubMed ID: 31390089
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
Ang PP; Tan GC; Karim N; Wong YP
Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4.
De Angelis M; Buley ID; Heryet A; Gray W
Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160
[TBL] [Abstract][Full Text] [Related]
12. Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash.
Carneiro FP; Muniz-Junqueira MI; De Vasconcelos Carneiro M; De Araújo Oliveira Í; Soares AC; De Vargas Haar N; Takano GHS; De Sousa Vianna LM; De Carvalho Caldas G; Vieira DLM; Frutuoso LL; Brito LMR; De Siqueira RVM; Parente AM; De Castro TMML; Peres I; Mendes LMS; Dos Santos Borges TK; Ferreira VM; Motoyama AB
Oncol Lett; 2019 Aug; 18(2):2019-2024. PubMed ID: 31423273
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Epithelial Cell Adhesion Molecule Flow Cytometry for Diagnosis of Metastatic Carcinoma in Serous Effusions.
Khodadadi N; Mokhtari M
Acta Cytol; 2023; 67(3):265-272. PubMed ID: 36626892
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
15. Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settings.
Arora R; Agarwal S; Mathur SR; Verma K; Iyer VK; Aron M
Cytojournal; 2011; 8():14. PubMed ID: 21829416
[TBL] [Abstract][Full Text] [Related]
16. MOC-31 Antibody Immunolabeling During Mohs Surgery.
Bae E; Saap L; Breen C; Iwamoto S
Dermatol Surg; 2022 Jun; 48(6):595-600. PubMed ID: 35384902
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
Risberg B; Davidson B; Dong HP; Nesland JM; Berner A
J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174
[TBL] [Abstract][Full Text] [Related]
18. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection.
Gill P; Naugler C; Abi Daoud MS
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens.
Maguire B; Whitaker D; Carrello S; Spagnolo D
Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591
[TBL] [Abstract][Full Text] [Related]
20. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]